Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.44 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.40 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.40 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1593157 | 0.94 | MEN1 (0.44) | PTGDR2MKNK2NR3C1AAK1MEN1 | |
| SCHEMBL1592875 | 0.87 | NR3C1 (0.45) | PTGDR2NR3C1AKR1C3MEN1KMT2A | |
| SCHEMBL1592988 | 0.80 | MEN1 (0.47) | PTGDR2NR3C1MEN1KMT2AHPGD | |
| SCHEMBL28425625 | 0.79 | PDE1B (0.48) | MEN1KMT2AALDH1A1SMN1; SMN2CNR1 | |
| SCHEMBL28431943 | 0.77 | PDE1B (0.49) | MEN1KMT2AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL28428236 | 0.77 | PDE1B (0.47) | NR3C1AKR1C3MEN1KMT2AHPGD | |
| SCHEMBL24566406 | 0.77 | CNR1 (0.50) | HPGDHSD17B10ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL28431878 | 0.74 | CNR1 (0.47) | HPGDHSD17B10ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL1593023 | 0.74 | CNR1 (0.47) | MEN1KMT2AHPGDHSD17B10ALDH1A1 | |
| SCHEMBL1592906 | 0.74 | PDE1B (0.55) | HPGDHSD17B10ALDH1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109846843-A | Desloratadine oral disnitegration tablet | 浙江普利药业有限公司 | 2019-06-07 | — | — | CN | claimed |
| EP-2233543-B1 | Composition for producing porous EVA coatings | ROHM & HAAS (US) | 2014-07-23 | — | — | EP | disclosed |
| US-8394795-B2 | Pyrazole [3, 4-B] pyridine Raf inhibitors | ARRAY BIOPHARMA INC. (US) | 2013-03-12 | — | — | US | disclosed |
| EP-2265610-B1 | PYRAZOLE [3, 4-B]PYRIDINE RAF INHIBITORS | ARRAY BIOPHARMA INC (US) | 2012-12-12 | — | — | EP | disclosed |
| US-8323746-B2 | Composition for producing porous EVA coatings | ROHM AND HAAS COMPANY (US) | 2012-12-04 | — | — | US | disclosed |
| US-20110092479-A1 | PYRAZOLE [3, 4-B] PYRIDINE RAF INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2011-04-21 | — | — | US | disclosed |
| EP-2265610-A1 | PYRAZOLE [3, 4-B]PYRIDINE RAF INHIBITORS | Array Biopharma, Inc. (US) | 2010-12-29 | — | — | EP | disclosed |
| US-20100247788-A1 | COMPOSITION FOR PRODUCING POROUS EVA COATINGS | ROHM AND HAAS COMPANY | 2010-09-30 | — | — | US | disclosed |
| EP-2233543-A1 | Composition for producing porous EVA coatings | Rohm and Haas Company (US) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009111279-A1 | PYRAZOLE [3, 4-B] PYRIDINE RAF INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2009-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110092479-A1 | PYRAZOLE [3, 4-B] PYRIDINE RAF INHIBITORS | BRAF, RAF1, ARAF | PTGDR2 2285/4885MKNK2 360/4885NR3C1 1529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.